The business combination of Voyager Acquisition Corp (VACH/W/U) and Veraxa Biotech AG closed on June 8, 2026. The ordinary shares, warrant, and unit of Voyager Acquisition Corp (VACH/W/U) will be suspended from trading effective on 6/11/2026. The suspension details are as follows:
| Company Name/Issue: |
Voyager Acquisition Corp Class A Ordinary Shares |
| CUSIP#: |
G93A7H104 |
| Symbol: |
VACH |
| Last Trading Date: |
June 10, 2026 |
| Marketplace Effective Date for Suspension: |
June 11, 2026 |
| Merger Consideration: |
One (1) Veraxa Biotech AG Ordinary Share (VRXA) for each share held. |
| Company Name/Issue: |
Voyager Acquisition Corp Warrant |
| CUSIP#: |
G93A7H112 |
| Symbol: |
VACHW |
| Last Trading Date: |
June 10, 2026 |
| Marketplace Effective Date for Suspension: |
June 11, 2026 |
| Merger Consideration: |
One (1) Veraxa Biotech AG Warrant expiring 6/8/2031 (VRXAW) for each warrant held. |
| Company Name/Issue: |
Voyager Acquisition Corp Unit |
| CUSIP#: |
G93A7H120 |
| Symbol: |
VACHU |
| Last Trading Date: |
June 10, 2026 |
| Marketplace Effective Date for Suspension: |
June 11, 2026 |
| Merger Consideration: |
Unit will separate into its components. |
The combined company will be domiciled in Switzerland and will list its ordinary shares (VRXA) on the Nasdaq Global Market and its warrants (VRXAW) on the Nasdaq Capital Market effective on June 11, 2026. The details are as follows:
| Company Name/Issue: |
Veraxa Biotech AG Ordinary Shares
|
| CUSIP#: |
H9130A103
|
| Symbol: |
VRXA |
| Marketplace Effective Date: |
June 11, 2026
|
| Company Name/Issue: |
Veraxa Biotech AG warrant expiring 6/8/2031
|
| CUSIP#: |
H9130A111
|
| Symbol: |
VRXAW |
| Marketplace Effective Date: |
June 11, 2026
|
If you would like to register as a market maker in VRXA or VRXAW contact Nasdaq Trading Services at +1 212 231 5100.
RSS Feeds
Product Login
